Full Text View
Tabular View
No Study Results Posted
Related Studies
Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-Effects (ART2)
This study is ongoing, but not recruiting participants.
Study NCT00497458   Information provided by Chavah Pty Ltd
First Received: July 4, 2007   Last Updated: April 7, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Arthralgia
Osteoporosis
Additional conditions recognized in this trial
Breast Neoplasms
More general conditions related to this trial
Bone Diseases
Bone Diseases, Metabolic
Breast Diseases
Joint Diseases
Musculoskeletal Diseases
Neoplasms
Neoplasms by Site
Pain
Signs and Symptoms
Skin Diseases
Interventions listed in this trial
Testosterone
Additional drug interventions recognized in this trial
Aromatase Inhibitors
Methyltestosterone
Testosterone 17 beta-cypionate
More general drug interventions related to this trial
Anabolic Agents
Androgens
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Enzyme Inhibitors
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Chavah Pty Ltd
AstraZeneca


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services